Eloxx Pharmaceuticals Future Growth
Future criteria checks 0/6
Eloxx Pharmaceuticals's EPS is expected to grow by 3.5% per annum.
Key information
n/a
Earnings growth rate
3.5%
EPS growth rate
Pharmaceuticals earnings growth | 22.8% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 12 Feb 2024 |
Recent future growth updates
Recent updates
Eloxx says lead asset failed in mid-stage cystic fibrosis trial
Sep 14Eloxx Pharmaceuticals GAAP EPS of -$0.12 in-line
Aug 15Is Eloxx Pharmaceuticals (NASDAQ:ELOX) Using Debt In A Risky Way?
Sep 09Eloxx Pharmaceuticals EPS misses by $0.06
May 06What Kind Of Investors Own Most Of Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX)?
Feb 17Eloxx secures additional funding from CF Foundation for ELX-02 mid-stage study in cystic fibrosis
Jan 13Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | N/A | N/A | N/A | N/A | 1 |
12/31/2025 | N/A | N/A | N/A | N/A | 1 |
12/31/2024 | N/A | N/A | N/A | N/A | 1 |
12/31/2023 | N/A | N/A | N/A | N/A | 1 |
9/30/2023 | N/A | -20 | -18 | -18 | N/A |
6/30/2023 | N/A | -24 | -22 | -21 | N/A |
3/31/2023 | N/A | -31 | -29 | -29 | N/A |
12/31/2022 | N/A | -36 | -32 | -32 | N/A |
9/30/2022 | N/A | -42 | -36 | -36 | N/A |
6/30/2022 | N/A | -44 | -37 | -37 | N/A |
3/31/2022 | N/A | -70 | -37 | -37 | N/A |
12/31/2021 | N/A | -67 | -35 | -35 | N/A |
9/30/2021 | N/A | -61 | -30 | -30 | N/A |
6/30/2021 | N/A | -57 | -27 | -27 | N/A |
3/31/2021 | N/A | -29 | -24 | -24 | N/A |
12/31/2020 | N/A | -35 | -28 | -28 | N/A |
9/30/2020 | N/A | -40 | -33 | -33 | N/A |
6/30/2020 | N/A | -46 | -39 | -39 | N/A |
3/31/2020 | N/A | -53 | -42 | -42 | N/A |
12/31/2019 | N/A | -51 | -39 | -39 | N/A |
9/30/2019 | N/A | -53 | -39 | -39 | N/A |
6/30/2019 | N/A | -52 | -36 | -36 | N/A |
3/31/2019 | N/A | -51 | -35 | -35 | N/A |
12/31/2018 | N/A | -47 | -32 | -31 | N/A |
9/30/2018 | N/A | -45 | -29 | -29 | N/A |
6/30/2018 | N/A | -38 | -24 | -24 | N/A |
3/31/2018 | N/A | -29 | -19 | -19 | N/A |
12/31/2017 | N/A | -24 | -16 | -16 | N/A |
9/30/2017 | N/A | -16 | -14 | -14 | N/A |
12/31/2016 | N/A | -11 | N/A | -9 | N/A |
12/31/2015 | N/A | -7 | N/A | -6 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if ELOX's forecast earnings growth is above the savings rate (2.4%).
Earnings vs Market: Insufficient data to determine if ELOX's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if ELOX's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if ELOX's revenue is forecast to grow faster than the US market.
High Growth Revenue: ELOX is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ELOX's Return on Equity is forecast to be high in 3 years time